<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03719612</url>
  </required_header>
  <id_info>
    <org_study_id>DEF-315</org_study_id>
    <nct_id>NCT03719612</nct_id>
  </id_info>
  <brief_title>DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY</brief_title>
  <acronym>BENEFIT2</acronym>
  <official_title>A Phase III, Open-Label, Multicenter Trial to Evaluate Ejection Fraction, End-Diastolic and End-Systolic Volumes, by Unenhanced and DEFINITY®-Enhanced 2D-Echo and Magnetic Resonance Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lantheus Medical Imaging</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Syneos Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lantheus Medical Imaging</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Phase 3, prospective, open-label, multicenter study to evaluate Left Ventricular&#xD;
      Ejection Fraction (LVEF) measurement accuracy and reproducibility of DEFINITY®&#xD;
      contrast-enhanced and unenhanced echocardiography as compared with non-contrast cardiac&#xD;
      magnetic resonance imaging (CMR) used as the truth standard.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 28, 2018</start_date>
  <completion_date type="Actual">January 9, 2020</completion_date>
  <primary_completion_date type="Actual">January 9, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Absolute Value of LVEF Percentage Differences From CMR by Blinded Reader</measure>
    <time_frame>Up to 30 days between day of echocardiograms and CMR imaging</time_frame>
    <description>Demonstrate improvement in accuracy in left ventricular ejection fraction (LVEF) assessment using DEFINITY® contrast-enhanced over unenhanced echocardiography by comparing LVEF percentage differences from CMR measured by 3 independent blinded image readers.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary Objective 1: Absolute Value of LVEF Percentage Differences From CMR by Blinded Reader for Sub-optimal Echocardiograms</measure>
    <time_frame>Up to 30 days between day of echocardiogram and CMR imaging</time_frame>
    <description>Demonstrate improvement in accuracy in left ventricular ejection fraction (LVEF) assessment using DEFINITY® contrast-enhanced over unenhanced echocardiography in subjects with suboptimal echocardiograms by comparing LVEF percentage differences from CMR measured by 3 independent blinded readers.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Objective 2: Absolute Value LVEF Percentage Differences From CMR Between Blinded Readers</measure>
    <time_frame>Up to 30 days between day of echocardiograms and CMR imaging</time_frame>
    <description>Demonstrate a reduction in inter-reader variability for the assessment of left ventricular ejection fraction using DEFINITY® contrast-enhanced versus unenhanced echocardiography by comparing LVEF percentage differences from CMR between 3 independent blinded readers.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Objective 3: Absolute Value End-diastolic and Systolic Volume Differences From CMR Between Blinded Readers</measure>
    <time_frame>Up to 30 days between day of echocardiogram and CMR imaging</time_frame>
    <description>Demonstrate a reduction in inter-reader variability for the assessment of end-diastolic/systolic volumes using DEFINITY® contrast-enhanced versus unenhanced echocardiography by comparing end-diastolic and systolic volume differences from CMR between 3 independent blinded readers.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Objective 4: Absolute Value of LVEF Percentage Differences From CMR Between Readers for Sub-optimal Echocardiograms</measure>
    <time_frame>Up to 30 days between day of echocardiograms and CMR imaging</time_frame>
    <description>Demonstrate a reduction in inter-reader variability for the assessment of left ventricular ejection fraction using DEFINITY® contrast-enhanced versus unenhanced echocardiography by comparing LVEF percentage differences from CMR between 3 independent blinded readers in subjects with suboptimal echocardiograms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Objective 5: Absolute Value End-diastolic and Systolic Volume Differences From CMR Between Blinded Readers for Suboptimal Echocardiograms</measure>
    <time_frame>Up to 30 days between day of echocardiograms and CMR imaging</time_frame>
    <description>Demonstrate a reduction in inter-reader variability for the assessment of end-diastolic/systolic volumes using DEFINITY® contrast-enhanced versus unenhanced echocardiography by comparing end-diastolic and systolic volume differences from CMR between 3 independent blinded readers in subjects with suboptimal echocardiograms.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Cardiac Disease</condition>
  <arm_group>
    <arm_group_label>DEFINITY®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each patient will undergo an unenhanced ultrasound examination and a DEFINITY® contrast-enhanced ultrasound</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DEFINITY®</intervention_name>
    <description>All subjects will receive a single dose of DEFINITY®</description>
    <arm_group_label>DEFINITY®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Men and women ≥ 18 years of age in sinus rhythm&#xD;
&#xD;
          2. Able to communicate effectively with trial personnel&#xD;
&#xD;
          3. LVEF measurements obtained via 2D Echo with or without contrast obtained within 6&#xD;
             months prior to enrollment (Day 0)&#xD;
&#xD;
          4. Has provided signed informed consent after receiving a verbal and written explanation&#xD;
             of this clinical trial&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Female subjects who are pregnant or lactating. All women of child bearing potential&#xD;
             [WOCBP] must have a negative urine pregnancy test at screening regardless of&#xD;
             contraceptive use history.&#xD;
&#xD;
          2. Women of child-bearing potential are excluded unless they:&#xD;
&#xD;
               1. are post-menopausal defined as amenorrhea ≥ 12 consecutive months, OR&#xD;
&#xD;
               2. have undergone successful surgical sterilization (hysterectomy, bilateral tubal&#xD;
                  ligation or bilateral oophorectomy), OR&#xD;
&#xD;
               3. have been using an adequate and medically approved method of contraception to&#xD;
                  avoid pregnancy for at least 1 month prior to DEFINITY® dose administration and&#xD;
                  be willing to continue using the same method for the duration of the study.&#xD;
&#xD;
          3. Current illness or pathology that would prevent undergoing investigational product&#xD;
             administration due to a significant safety risk to the patient.&#xD;
&#xD;
          4. Uncontrolled arterial hypertension (defined as systolic blood pressure ≥ 200 mmHg or&#xD;
             diastolic blood pressure ≥ 110 mmHg) or arterial hypotension (defined as systolic&#xD;
             blood pressure ≤ 90 mmHg).&#xD;
&#xD;
          5. Unstable cardiovascular status defined as:&#xD;
&#xD;
               1. myocardial infarction or unstable angina pectoris within 6 months prior to&#xD;
                  enrollment/DEFINITY® dose administration day&#xD;
&#xD;
               2. transient ischemic attack or stroke within 3 months prior to DEFINITY® dose&#xD;
                  administration&#xD;
&#xD;
               3. symptomatic valvular heart disease or moderate to severe stenotic valvular heart&#xD;
                  disease&#xD;
&#xD;
               4. clinically significant congenital heart defects&#xD;
&#xD;
               5. current uncontrolled cardiac arrhythmias causing symptoms or hemodynamic&#xD;
                  compromise&#xD;
&#xD;
               6. acute pulmonary embolus or pulmonary infarction&#xD;
&#xD;
               7. acute myocarditis or pericarditis&#xD;
&#xD;
               8. acute aortic dissection&#xD;
&#xD;
               9. atrial fibrillation&#xD;
&#xD;
          6. any major surgery within 4 weeks prior to screening&#xD;
&#xD;
          7. known contraindications to undergoing CMR (e.g. implanted pacemakers, cardioverter,&#xD;
             defibrillators) or claustrophobia&#xD;
&#xD;
          8. participation in any investigational drug, device, or placebo study within 30 days&#xD;
             prior to screening&#xD;
&#xD;
          9. known hypersensitivity to perflutren, or any of the excipients in DEFINITY®&#xD;
&#xD;
         10. prisoners or those who are subject to compulsory detention or involuntary&#xD;
             incarceration for treatment of either a psychiatric or physical illness (e.g.,&#xD;
             infectious disease).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Banner University of Arizona Medical Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cedars Sinai</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California-Irvine</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UC San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alfieri Cardiology</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern Medical Group</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Bloomington</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist Hospital</name>
      <address>
        <city>Paducah</city>
        <state>Kentucky</state>
        <zip>42003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Unit Hospital</name>
      <address>
        <city>Coon Rapids</city>
        <state>Minnesota</state>
        <zip>55433</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Sciences University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albert Einstein Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19412</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor Scott White Research Institute</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>September 28, 2018</study_first_submitted>
  <study_first_submitted_qc>October 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2018</study_first_posted>
  <results_first_submitted>December 11, 2020</results_first_submitted>
  <results_first_submitted_qc>December 11, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 7, 2021</results_first_posted>
  <last_update_submitted>January 7, 2021</last_update_submitted>
  <last_update_submitted_qc>January 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Left Ventricular Ejection Fraction</keyword>
  <keyword>DEFINITY®</keyword>
  <keyword>Enhanced Echocardiogram</keyword>
  <keyword>Cardiac Magnetic Resonance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 15, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/12/NCT03719612/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 31, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/12/NCT03719612/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>DEFINITY®</title>
          <description>Each patient will undergo an unenhanced ultrasound examination and a DEFINITY® contrast-enhanced ultrasound&#xD;
DEFINITY®: All subjects will receive a single dose of DEFINITY®</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="160"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="148"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Baseline data are calculated based on Safety Population</population>
      <group_list>
        <group group_id="B1">
          <title>DEFINITY®</title>
          <description>Each patient will undergo an unenhanced ultrasound examination and a DEFINITY® contrast-enhanced ultrasound&#xD;
DEFINITY®: All subjects will receive a single dose of DEFINITY®</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="160"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="106"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="146"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="120"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>LVEF Group</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>LVEF &lt;30%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LVEF 30-40%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LVEF 41-50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LVEF &gt;50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Absolute Value of LVEF Percentage Differences From CMR by Blinded Reader</title>
        <description>Demonstrate improvement in accuracy in left ventricular ejection fraction (LVEF) assessment using DEFINITY® contrast-enhanced over unenhanced echocardiography by comparing LVEF percentage differences from CMR measured by 3 independent blinded image readers.</description>
        <time_frame>Up to 30 days between day of echocardiograms and CMR imaging</time_frame>
        <population>Modified ITT Population</population>
        <group_list>
          <group group_id="O1">
            <title>Blinded Reader 1</title>
            <description>Independent Blinded Reader 1 of 3</description>
          </group>
          <group group_id="O2">
            <title>Blinded Reader 2</title>
            <description>Independent Blinded Reader 2 of 3</description>
          </group>
          <group group_id="O3">
            <title>Blinded Reader 3</title>
            <description>Independent Blinded Reader 3 of 3</description>
          </group>
        </group_list>
        <measure>
          <title>Absolute Value of LVEF Percentage Differences From CMR by Blinded Reader</title>
          <description>Demonstrate improvement in accuracy in left ventricular ejection fraction (LVEF) assessment using DEFINITY® contrast-enhanced over unenhanced echocardiography by comparing LVEF percentage differences from CMR measured by 3 independent blinded image readers.</description>
          <population>Modified ITT Population</population>
          <units>Percent Ejection Fraction</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="144"/>
                <count group_id="O2" value="144"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Echo Enhanced</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.70" spread="4.292"/>
                    <measurement group_id="O2" value="5.88" spread="4.330"/>
                    <measurement group_id="O3" value="5.03" spread="3.548"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Echo Unenhanced</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.08" spread="4.530"/>
                    <measurement group_id="O2" value="6.00" spread="4.813"/>
                    <measurement group_id="O3" value="5.36" spread="3.889"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Difference between Echo Enhanced and Echo Unenhanced</non_inferiority_desc>
            <p_value>0.358</p_value>
            <method>t-test, 2 sided</method>
            <method_desc>Paired t-test</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.38</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>4.947</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Difference between Echo Enhanced and Echo Unenhanced</non_inferiority_desc>
            <p_value>0.804</p_value>
            <method>t-test, 2 sided</method>
            <method_desc>Paired t-test</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.12</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>5.699</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Difference between Echo Enhanced and Echo Unenhanced</non_inferiority_desc>
            <p_value>0.371</p_value>
            <method>t-test, 2 sided</method>
            <method_desc>Paired t-test</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.33</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>4.412</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Secondary Objective 1: Absolute Value of LVEF Percentage Differences From CMR by Blinded Reader for Sub-optimal Echocardiograms</title>
        <description>Demonstrate improvement in accuracy in left ventricular ejection fraction (LVEF) assessment using DEFINITY® contrast-enhanced over unenhanced echocardiography in subjects with suboptimal echocardiograms by comparing LVEF percentage differences from CMR measured by 3 independent blinded readers.</description>
        <time_frame>Up to 30 days between day of echocardiogram and CMR imaging</time_frame>
        <population>Modified ITT Population - Sub-optimal Echocardiograms</population>
        <group_list>
          <group group_id="O1">
            <title>Blinded Reader 1</title>
            <description>Independent Blinded Reader 1 of 3</description>
          </group>
          <group group_id="O2">
            <title>Blinded Reader 2</title>
            <description>Independent Blinded Reader 2 of 3</description>
          </group>
          <group group_id="O3">
            <title>Blinded Reader 3</title>
            <description>Independent Blinded Reader 3 of 3</description>
          </group>
        </group_list>
        <measure>
          <title>Secondary Objective 1: Absolute Value of LVEF Percentage Differences From CMR by Blinded Reader for Sub-optimal Echocardiograms</title>
          <description>Demonstrate improvement in accuracy in left ventricular ejection fraction (LVEF) assessment using DEFINITY® contrast-enhanced over unenhanced echocardiography in subjects with suboptimal echocardiograms by comparing LVEF percentage differences from CMR measured by 3 independent blinded readers.</description>
          <population>Modified ITT Population - Sub-optimal Echocardiograms</population>
          <units>Percent Ejection Fraction</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
                <count group_id="O3" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Echo Enhanced</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.67" spread="3.717"/>
                    <measurement group_id="O2" value="6.16" spread="3.746"/>
                    <measurement group_id="O3" value="4.68" spread="3.456"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Echo Unenhanced</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.95" spread="5.219"/>
                    <measurement group_id="O2" value="6.81" spread="4.694"/>
                    <measurement group_id="O3" value="5.33" spread="3.764"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Difference between Echo Enhanced and Echo Unenhanced</non_inferiority_desc>
            <p_value>0.030</p_value>
            <method>t-test, 2 sided</method>
            <method_desc>Paired t-test</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.28</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>3.952</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Difference between Echo Enhanced and Echo Unenhanced</non_inferiority_desc>
            <p_value>0.312</p_value>
            <method>t-test, 2 sided</method>
            <method_desc>Paired t-test</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.66</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>4.466</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Difference between Echo Enhanced and Echo Unenhanced</non_inferiority_desc>
            <p_value>0.347</p_value>
            <method>t-test, 2 sided</method>
            <method_desc>Paired t-test</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.65</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>4.725</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Secondary Objective 2: Absolute Value LVEF Percentage Differences From CMR Between Blinded Readers</title>
        <description>Demonstrate a reduction in inter-reader variability for the assessment of left ventricular ejection fraction using DEFINITY® contrast-enhanced versus unenhanced echocardiography by comparing LVEF percentage differences from CMR between 3 independent blinded readers.</description>
        <time_frame>Up to 30 days between day of echocardiograms and CMR imaging</time_frame>
        <population>Modified ITT Population</population>
        <group_list>
          <group group_id="O1">
            <title>Blinded Reader 1</title>
            <description>Independent Blinded Reader 1 of 3</description>
          </group>
          <group group_id="O2">
            <title>Blinded Reader 2</title>
            <description>Independent Blinded Reader 2 of 3</description>
          </group>
          <group group_id="O3">
            <title>Blinded Reader 3</title>
            <description>Independent Blinded Reader 3 of 3</description>
          </group>
        </group_list>
        <measure>
          <title>Secondary Objective 2: Absolute Value LVEF Percentage Differences From CMR Between Blinded Readers</title>
          <description>Demonstrate a reduction in inter-reader variability for the assessment of left ventricular ejection fraction using DEFINITY® contrast-enhanced versus unenhanced echocardiography by comparing LVEF percentage differences from CMR between 3 independent blinded readers.</description>
          <population>Modified ITT Population</population>
          <units>Percent Ejection Fraction</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="144"/>
                <count group_id="O2" value="144"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Echo Enhanced</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.70" spread="4.292"/>
                    <measurement group_id="O2" value="5.88" spread="4.330"/>
                    <measurement group_id="O3" value="5.03" spread="3.548"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Echo Unenhanced</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.08" spread="4.530"/>
                    <measurement group_id="O2" value="6.00" spread="4.813"/>
                    <measurement group_id="O3" value="5.36" spread="3.889"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability Echo Enhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.984</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.977</ci_lower_limit>
            <ci_upper_limit>0.988</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability Echo Unenhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.953</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.936</ci_lower_limit>
            <ci_upper_limit>0.966</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability Echo Enhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.970</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.958</ci_lower_limit>
            <ci_upper_limit>0.978</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability Echo Unenhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.944</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.923</ci_lower_limit>
            <ci_upper_limit>0.959</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability Echo Enhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.961</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.947</ci_lower_limit>
            <ci_upper_limit>0.972</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability Echo Unenhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.942</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.920</ci_lower_limit>
            <ci_upper_limit>0.958</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Secondary Objective 3: Absolute Value End-diastolic and Systolic Volume Differences From CMR Between Blinded Readers</title>
        <description>Demonstrate a reduction in inter-reader variability for the assessment of end-diastolic/systolic volumes using DEFINITY® contrast-enhanced versus unenhanced echocardiography by comparing end-diastolic and systolic volume differences from CMR between 3 independent blinded readers.</description>
        <time_frame>Up to 30 days between day of echocardiogram and CMR imaging</time_frame>
        <population>Modified ITT Population</population>
        <group_list>
          <group group_id="O1">
            <title>Blinded Reader 1</title>
            <description>Independent Blinded Reader 1 of 3</description>
          </group>
          <group group_id="O2">
            <title>Blinded Reader 2</title>
            <description>Independent Blinded Reader 2 of 3</description>
          </group>
          <group group_id="O3">
            <title>Blinded Reader 3</title>
            <description>Independent Blinded Reader 3 of 3</description>
          </group>
        </group_list>
        <measure>
          <title>Secondary Objective 3: Absolute Value End-diastolic and Systolic Volume Differences From CMR Between Blinded Readers</title>
          <description>Demonstrate a reduction in inter-reader variability for the assessment of end-diastolic/systolic volumes using DEFINITY® contrast-enhanced versus unenhanced echocardiography by comparing end-diastolic and systolic volume differences from CMR between 3 independent blinded readers.</description>
          <population>Modified ITT Population</population>
          <units>mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="144"/>
                <count group_id="O2" value="144"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Echo Enhanced End Diastolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.85" spread="44.204"/>
                    <measurement group_id="O2" value="51.13" spread="43.391"/>
                    <measurement group_id="O3" value="47.97" spread="40.589"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Echo Unenhanced End Diastolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.91" spread="44.084"/>
                    <measurement group_id="O2" value="62.01" spread="43.392"/>
                    <measurement group_id="O3" value="48.32" spread="39.895"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Echo Enhanced End Systolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.05" spread="32.921"/>
                    <measurement group_id="O2" value="32.41" spread="32.896"/>
                    <measurement group_id="O3" value="31.68" spread="30.603"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Echo Unenhanced End Systolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.87" spread="34.793"/>
                    <measurement group_id="O2" value="39.08" spread="34.139"/>
                    <measurement group_id="O3" value="32.45" spread="31.314"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Diastolic Echo Enhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.984</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.978</ci_lower_limit>
            <ci_upper_limit>0.988</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Diastolic Echo Unenhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.976</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.967</ci_lower_limit>
            <ci_upper_limit>0.983</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Diastolic Echo Enhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.973</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.963</ci_lower_limit>
            <ci_upper_limit>0.981</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Diastolic Echo Unenhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.935</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.910</ci_lower_limit>
            <ci_upper_limit>0.952</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Diastolic Echo Enhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.973</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.962</ci_lower_limit>
            <ci_upper_limit>0.980</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Diastolic Echo Unenhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.924</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.896</ci_lower_limit>
            <ci_upper_limit>0.945</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Systolic Echo Enhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.989</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.984</ci_lower_limit>
            <ci_upper_limit>0.992</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Systolic Echo Unenhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.983</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.977</ci_lower_limit>
            <ci_upper_limit>0.988</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Systolic Echo Enhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.984</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.978</ci_lower_limit>
            <ci_upper_limit>0.989</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Systolic Echo Unenhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.948</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.928</ci_lower_limit>
            <ci_upper_limit>0.962</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Systolic Echo Enhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.978</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.969</ci_lower_limit>
            <ci_upper_limit>0.984</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Systolic Echo Unenhanced</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.942</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.920</ci_lower_limit>
            <ci_upper_limit>0.958</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Secondary Objective 4: Absolute Value of LVEF Percentage Differences From CMR Between Readers for Sub-optimal Echocardiograms</title>
        <description>Demonstrate a reduction in inter-reader variability for the assessment of left ventricular ejection fraction using DEFINITY® contrast-enhanced versus unenhanced echocardiography by comparing LVEF percentage differences from CMR between 3 independent blinded readers in subjects with suboptimal echocardiograms.</description>
        <time_frame>Up to 30 days between day of echocardiograms and CMR imaging</time_frame>
        <population>Modified ITT Population - Sub-optimal Echocardiograms</population>
        <group_list>
          <group group_id="O1">
            <title>Blinded Reader 1</title>
            <description>Independent Blinded Reader 1 of 3</description>
          </group>
          <group group_id="O2">
            <title>Blinded Reader 2</title>
            <description>Independent Blinded Reader 2 of 3</description>
          </group>
          <group group_id="O3">
            <title>Blinded Reader 3</title>
            <description>Independent Blinded Reader 3 of 3</description>
          </group>
        </group_list>
        <measure>
          <title>Secondary Objective 4: Absolute Value of LVEF Percentage Differences From CMR Between Readers for Sub-optimal Echocardiograms</title>
          <description>Demonstrate a reduction in inter-reader variability for the assessment of left ventricular ejection fraction using DEFINITY® contrast-enhanced versus unenhanced echocardiography by comparing LVEF percentage differences from CMR between 3 independent blinded readers in subjects with suboptimal echocardiograms.</description>
          <population>Modified ITT Population - Sub-optimal Echocardiograms</population>
          <units>Percent Ejection Fraction</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
                <count group_id="O3" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Echo Enhanced</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.67" spread="3.717"/>
                    <measurement group_id="O2" value="6.16" spread="3.746"/>
                    <measurement group_id="O3" value="4.68" spread="3.456"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Echo Unenhanced</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.95" spread="5.219"/>
                    <measurement group_id="O2" value="6.81" spread="4.694"/>
                    <measurement group_id="O3" value="5.33" spread="3.764"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability Echo Enhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.975</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.956</ci_lower_limit>
            <ci_upper_limit>0.986</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability Echo Unenhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.936</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.888</ci_lower_limit>
            <ci_upper_limit>0.963</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability Echo Enhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.961</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.931</ci_lower_limit>
            <ci_upper_limit>0.978</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability Echo Unenhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.921</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.864</ci_lower_limit>
            <ci_upper_limit>0.955</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability Echo Enhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.947</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.907</ci_lower_limit>
            <ci_upper_limit>0.970</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability Echo Unenhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.903</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.834</ci_lower_limit>
            <ci_upper_limit>0.945</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Secondary Objective 5: Absolute Value End-diastolic and Systolic Volume Differences From CMR Between Blinded Readers for Suboptimal Echocardiograms</title>
        <description>Demonstrate a reduction in inter-reader variability for the assessment of end-diastolic/systolic volumes using DEFINITY® contrast-enhanced versus unenhanced echocardiography by comparing end-diastolic and systolic volume differences from CMR between 3 independent blinded readers in subjects with suboptimal echocardiograms.</description>
        <time_frame>Up to 30 days between day of echocardiograms and CMR imaging</time_frame>
        <population>Modified ITT Population - Sub-optimal Echocardiograms</population>
        <group_list>
          <group group_id="O1">
            <title>Blinded Reader 1</title>
            <description>Independent Blinded Reader 1 of 3</description>
          </group>
          <group group_id="O2">
            <title>Blinded Reader 2</title>
            <description>Independent Blinded Reader 2 of 3</description>
          </group>
          <group group_id="O3">
            <title>Blinded Reader 3</title>
            <description>Independent Blinded Reader 3 of 3</description>
          </group>
        </group_list>
        <measure>
          <title>Secondary Objective 5: Absolute Value End-diastolic and Systolic Volume Differences From CMR Between Blinded Readers for Suboptimal Echocardiograms</title>
          <description>Demonstrate a reduction in inter-reader variability for the assessment of end-diastolic/systolic volumes using DEFINITY® contrast-enhanced versus unenhanced echocardiography by comparing end-diastolic and systolic volume differences from CMR between 3 independent blinded readers in subjects with suboptimal echocardiograms.</description>
          <population>Modified ITT Population - Sub-optimal Echocardiograms</population>
          <units>mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
                <count group_id="O3" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Echo Enhanced End Diastolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.67" spread="49.916"/>
                    <measurement group_id="O2" value="63.73" spread="49.571"/>
                    <measurement group_id="O3" value="61.86" spread="47.523"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Echo Unenhanced End Diastolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.89" spread="51.468"/>
                    <measurement group_id="O2" value="69.07" spread="46.316"/>
                    <measurement group_id="O3" value="64.38" spread="46.827"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Echo Enhanced End Systolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.59" spread="32.844"/>
                    <measurement group_id="O2" value="38.55" spread="33.493"/>
                    <measurement group_id="O3" value="39.52" spread="30.946"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Echo Unenhanced End Systolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.00" spread="37.639"/>
                    <measurement group_id="O2" value="41.88" spread="32.989"/>
                    <measurement group_id="O3" value="40.72" spread="32.333"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Diastolic Echo Enhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.984</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.971</ci_lower_limit>
            <ci_upper_limit>0.991</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Diastolic Echo Unenhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.975</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.956</ci_lower_limit>
            <ci_upper_limit>0.986</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Diastolic Echo Enhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.977</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.959</ci_lower_limit>
            <ci_upper_limit>0.987</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Diastolic Echo Unenhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.940</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.896</ci_lower_limit>
            <ci_upper_limit>0.966</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Diastolic Echo Enhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.977</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.959</ci_lower_limit>
            <ci_upper_limit>0.987</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Diastolic Echo Unenhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.923</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.866</ci_lower_limit>
            <ci_upper_limit>0.956</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Systolic Echo Enhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.990</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.982</ci_lower_limit>
            <ci_upper_limit>0.994</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Systolic Echo Unenhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.976</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.957</ci_lower_limit>
            <ci_upper_limit>0.986</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Systolic Echo Enhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.985</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.973</ci_lower_limit>
            <ci_upper_limit>0.991</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Systolic Echo Unenhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.929</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.876</ci_lower_limit>
            <ci_upper_limit>0.959</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Systolic Echo Enhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.981</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.966</ci_lower_limit>
            <ci_upper_limit>0.989</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Inter-Reader Variability End Systolic Echo Unenhanced Sub-Optimal Echocardiograms</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Intra-class Correlation Coefficient</param_type>
            <param_value>0.916</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.855</ci_lower_limit>
            <ci_upper_limit>0.952</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 12 days: Enrolled subjects were followed for adverse events and serious adverse events from the time the Informed Consent was signed at screening (Day -7 to Day 0) through 72+/-24 hours after completion of Definity administration (Day 0).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>DEFINITY®</title>
          <description>Each patient will undergo an unenhanced ultrasound examination and a DEFINITY® contrast-enhanced ultrasound&#xD;
DEFINITY®: All subjects will receive a single dose of DEFINITY®</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="160"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="160"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="160"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="160"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Istvan Molnar</name_or_title>
      <organization>Lantheus Medical Imaging, Inc</organization>
      <phone>978-671-8686</phone>
      <email>istvan.molnar@lantheus.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

